[Federal Register: December 19, 2001 (Volume 66, Number 244)]
[Notices]
[Page 65505-65506]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr19de01-53]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Program Announcement 02019]
Cooperative Agreement for the Surveillance, Research, and
Prevention of Birth Defects; Notice of Availability of Funds
A. Purpose
The Centers for Disease Control and Prevention (CDC) announces the
availability of fiscal year (FY) 2002 funds for a cooperative agreement
program for the surveillance, research, and prevention of birth
defects. The purpose of this program is to aid in the surveillance,
research, and prevention of birth defects.
B. Eligible Applicants
Assistance will be provided only to the International Centre for
Birth Defects (ICBD). No other applications are solicited.
Located in Rome, Italy, ICBD was established in 1989 as an
organization devoted to the prevention of birth defects through
surveillance, training, and epidemiologic research. ICBD accomplishes
this by serving as the headquarters for the International Clearinghouse
for Birth Defects Monitoring Programs. The Clearinghouse is a non-
governmental organization comprised of 32 member programs representing
34 countries in Europe, the Americas, Japan, China, South Africa, and
Australia. The Clearinghouse's mission is to prevent birth defects
through the exchange of information, enabling collaborative research,
and consultation and assistance. Specifically, the Clearinghouse:
1. Responds to possible or suspected clusters of congenital
malformations with information, monitoring systems, and personnel so
that member countries are alerted and preventive action may be taken.
This is the primary and most enduring goal of the Clearinghouse;
2. Enables collaborative epidemiological research based on birth
defect surveillance data obtained from the member programs. Joint
studies with the member programs have attempted to provide an
understanding of endemic occurrence as well as temporal and/or
geographical clusters of malformations; and
3. Provides expert consultation and assistance.
Note: Title 2 of the United States Code, section 1611 states
that an organization described in section 501(c)(4) of the Internal
Revenue Code that engages in lobbying activities is not eligible to
receive Federal funds constituting an award, grant, or loan.
C. Availability of Funds
Approximately $150,000 is available in FY 2002 to fund this award.
It is expected that the award will begin on or about April 1, 2002, and
will be made for a 12-month budget period within a project period of up
to three years. Funding estimates may change.
Continuation awards within an approved project period will be made
on the basis of satisfactory progress as evidenced by required reports
and the availability of funds.
Use of Funds
Funds may be utilized only for the purpose and for the activities
described and approved in the final award.
1. All requests for funds contained in the budget shall be stated
in U.S. dollars. Once an award is made, CDC will not compensate foreign
grantees for currency exchange fluctuations through the issuance of
supplemental awards.
a. Funds may be spent for reasonable program purposes, including
personnel, travel, supplies, and services. Equipment may be purchased
if deemed necessary to accomplish program objectives, however, prior
approval by CDC officials must be requested in writing.
b. The costs that are generally allowable in grants to domestic
organizations are allowable to foreign institutions and international
organizations, with the following exception: Indirect costs will not be
paid (either directly or through sub-award) to organizations located
outside the territorial limits of the United States or to international
organizations regardless of their location.
c. The applicant may contract with other organizations under this
program. However, the applicant must perform a substantial portion of
the activities including program management and operations, and
delivery of prevention services for which funds are required.
D. Where To Obtain Additional Information
This and other CDC announcements can be found on the CDC home page
Internet address http://www.cdc.gov. Click on ``Funding'' then ``Grants
and Cooperative Agreements.''
To obtain business management technical assistance, contact:
Angelia D. Hill, Grants Management Specialist, International Grants and
Contracts Branch, Procurement and Grants Office, Centers for Disease
Control and
[[Page 65506]]
Prevention (CDC), 2920 Brandywine Road, Room 3000, Atlanta, GA 30341-
4146, Telephone: (770) 488-2785, E-mail address: aph8@cdc.gov.
Program technical assistance may be obtained from: J. David
Erickson, National Center on Birth Defects and Developmental
Disabilities, Centers for Disease Control and Prevention (CDC), 4770
Buford Highway NE., Atlanta, GA 30341-3724, Telephone: (770) 488-7161,
E-mail address: jde1@cdc.gov.
Dated: December 12, 2001.
Rebecca B. O'Kelley,
Chief, International Grants and Contracts Branch, Procurement and
Grants Office, Centers for Disease Control and Prevention (CDC).
[FR Doc. 01-31222 Filed 12-18-01; 8:45 am]
BILLING CODE 4163-18-P